by Indigo | May 15, 2023 | 2023, News, Press
Arun is an award-winning engineer who brings over 15 years’ experience in leading the design and development of transformational technology within the medical, consumer, and military sectors BELGIUM – Ghent, 15 May 2023 – Indigo Diabetes N.V. (‘Indigo’ or the...
by Indigo | May 5, 2023 | 2023, News
Indigo Diabetes nv. has completed the Hephaestus Research Project. In September 2021, Indigo received a €3 million Hephaestus grant from VLAIO, the Flanders organisation for Innovation & Entrepreneurship, to conduct research into the high-volume production of...
by Indigo | Feb 21, 2023 | 2023, News, Press
BELGIUM – Ghent, 21 February 2023: Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM®) devices utilising proprietary nanophotonics technology, today announces that that an abstract featuring its CMM®...
by Indigo | Jan 4, 2023 | 2023, News, Press
SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial Several key senior appointments made in Europe and the US, reflecting the growth and evolution from an early stage to a development stage...
by Indigo | Oct 27, 2022 | 2022, News, Press
Indigo establishes a US presence to drive business development and extend talent acquisition Peter brings over 30 years’ experience leading the development & commercialisation of medical devices, including devices for the diabetes market Ghent, 27 October...
by Indigo | Sep 29, 2022 | 2022, News
indigo diabetes announces first participant enrolled in the shine clinical trial BELGIUM – Ghent, September 29, 2022 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today announces the enrollment of...